-
1
-
-
0035804852
-
Association of cancer with AIDS-related immunosuppression in adults
-
Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
-
(2001)
JAMA
, vol.285
, pp. 1736-1745
-
-
Frisch, M.1
Biggar, R.J.2
Engels, E.A.3
Goedert, J.J.4
-
2
-
-
0035889139
-
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
-
Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood. 2001;98:2339-2344.
-
(2001)
Blood
, vol.98
, pp. 2339-2344
-
-
Besson, C.1
Goubar, A.2
Gabarre, J.3
-
3
-
-
0031588349
-
Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden. AIDS/Cancer Study Group
-
Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer. 1997;73:645-650.
-
(1997)
Int J Cancer
, vol.73
, pp. 645-650
-
-
Cote, T.R.1
Biggar, R.J.2
Rosenberg, P.S.3
-
4
-
-
0037697771
-
Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study
-
Oriol A, Ribera JM, Esteve J, et al. Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica. 2003;88:445-453.
-
(2003)
Haematologica
, vol.88
, pp. 445-453
-
-
Oriol, A.1
Ribera, J.M.2
Esteve, J.3
-
5
-
-
0042418171
-
Intensive chemotherapy with cyclophosphamide, doxorubicine, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma
-
Wang ES, Straus DJ, Teruya-Feldstein J, et al. Intensive chemotherapy with cyclophosphamide, doxorubicine, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 2003;98:1196-1205.
-
(2003)
Cancer
, vol.98
, pp. 1196-1205
-
-
Wang, E.S.1
Straus, D.J.2
Teruya-Feldstein, J.3
-
6
-
-
0036500980
-
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia
-
Cortes J, Thomas D, Rios A, et al. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer. 2002;94:1492-1499.
-
(2002)
Cancer
, vol.94
, pp. 1492-1499
-
-
Cortes, J.1
Thomas, D.2
Rios, A.3
-
7
-
-
0037105373
-
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection
-
Spina M, Gabarre J, Rossi G, et al. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood. 2002;100:1984-1988.
-
(2002)
Blood
, vol.100
, pp. 1984-1988
-
-
Spina, M.1
Gabarre, J.2
Rossi, G.3
-
8
-
-
35548946744
-
Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: A prospective study
-
Galicier L, Fieschi C, Borie R, et al. Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study. Blood. 2007;110: 2846-2854.
-
(2007)
Blood
, vol.110
, pp. 2846-2854
-
-
Galicier, L.1
Fieschi, C.2
Borie, R.3
-
9
-
-
22544467810
-
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study
-
Oriol A, Ribera JM, Brunet S, del Potro E, Abella E, Esteve J. Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study. Haematologica. 2005;90:990-992.
-
(2005)
Haematologica
, vol.90
, pp. 990-992
-
-
Oriol, A.1
Ribera, J.M.2
Brunet, S.3
del Potro, E.4
Abella, E.5
Esteve, J.6
-
10
-
-
23944508056
-
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
-
Kaplan LD, Lee JY, Ambinder RF, et al. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 2005;106:1538-1543.
-
(2005)
Blood
, vol.106
, pp. 1538-1543
-
-
Kaplan, L.D.1
Lee, J.Y.2
Ambinder, R.F.3
-
11
-
-
57649117155
-
High survival rate in adults Burkitt's lymphoma/leukemia and diffuse large B-cell lymphoma with mediastinal involvement
-
Hoelzer D, Hiddemann W, Baumann A, et al. High survival rate in adults Burkitt's lymphoma/leukemia and diffuse large B-cell lymphoma with mediastinal involvement. Blood. 2007;110: 159a.
-
(2007)
Blood
, vol.110
-
-
Hoelzer, D.1
Hiddemann, W.2
Baumann, A.3
-
12
-
-
13344285351
-
Improved outcome in adult B-cell acute lymphoblastic leukemia
-
Hoelzer D, Ludwig WD, Thiel E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood. 1996; 87:495-508.
-
(1996)
Blood
, vol.87
, pp. 495-508
-
-
Hoelzer, D.1
Ludwig, W.D.2
Thiel, E.3
-
13
-
-
0028064764
-
A revised European-American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
-
Harris NL, Jaffe ES, Stein H, et al. A revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84:1361-1392.
-
(1994)
Blood
, vol.84
, pp. 1361-1392
-
-
Harris, N.L.1
Jaffe, E.S.2
Stein, H.3
-
15
-
-
0034685037
-
Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
-
Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000;283:381-390.
-
(2000)
JAMA
, vol.283
, pp. 381-390
-
-
Carpenter, C.C.1
Cooper, D.A.2
Fischl, M.A.3
-
16
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
-
(1958)
J Am Stat Assoc
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
17
-
-
0017365573
-
-
Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: analysis and examples. Br J Cancer. 1977; 35:1-39.
-
Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, II: analysis and examples. Br J Cancer. 1977; 35:1-39.
-
-
-
-
18
-
-
0000336139
-
Regression models and life tables
-
Cox DR. Regression models and life tables. J Roy Stat Soc Ser B. 1972;34:187-220.
-
(1972)
J Roy Stat Soc Ser B
, vol.34
, pp. 187-220
-
-
Cox, D.R.1
-
19
-
-
0026762701
-
Acquired immunodeficiency syndrome-related lymphoma
-
Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood. 1992;80:8-20.
-
(1992)
Blood
, vol.80
, pp. 8-20
-
-
Levine, A.M.1
-
21
-
-
22344450861
-
AIDS-related Burkitt's lymphoma versus large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: Significant differences in survival with standard chemotherapy
-
Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM. AIDS-related Burkitt's lymphoma versus large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol. 2005;23: 4430-4438.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4430-4438
-
-
Lim, S.T.1
Karim, R.2
Nathwani, B.N.3
Tulpule, A.4
Espina, B.5
Levine, A.M.6
-
22
-
-
33745017226
-
Caspase-independent killing of Burkitt lymphoma cell lines by rituximab
-
Daniels I, Abulayha AM, Thomson BJ, Haynes AR Caspase-independent killing of Burkitt lymphoma cell lines by rituximab. Apoptosis. 2006;11:1013-1023.
-
(2006)
Apoptosis
, vol.11
, pp. 1013-1023
-
-
Daniels, I.1
Abulayha, A.M.2
Thomson, B.J.3
Haynes, A.R.4
-
23
-
-
38349112290
-
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma. Results of a phase II trial
-
Ribera JM, Oriol A, Morgades M, et al. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma. Results of a phase II trial. Br J Haematol. 2008;140:411-419.
-
(2008)
Br J Haematol
, vol.140
, pp. 411-419
-
-
Ribera, J.M.1
Oriol, A.2
Morgades, M.3
-
24
-
-
33645830511
-
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
-
Thomas DA, Faderl S, O'Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569-1580.
-
(2006)
Cancer
, vol.106
, pp. 1569-1580
-
-
Thomas, D.A.1
Faderl, S.2
O'Brien, S.3
-
25
-
-
47149117582
-
Long-term outcome after hyper-CVAD and rituximab chemoimmunotherapy for Burkitt or Burkitt-like leukemia/lymphoma and mature B-cell acute lymphocytic leukemia
-
Thomas DA, Kantarjian H, Cortes J, et al. Long-term outcome after hyper-CVAD and rituximab chemoimmunotherapy for Burkitt or Burkitt-like leukemia/lymphoma and mature B-cell acute lymphocytic leukemia. Blood. 2007;118: 831a.
-
(2007)
Blood
, vol.118
-
-
Thomas, D.A.1
Kantarjian, H.2
Cortes, J.3
|